Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Roots applicable, high sensitivity and specificity assay for the detection of<i> Candidatus</i> Liberibacter asiaticus in<i> citrus</i> roots and fruits

Micronanoparticled risedronate exhibits potent vaccine adjuvant effects

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression <i>in vivo</i>

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus

Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression

Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26

Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient

An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease

A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

Comparison of HPV neutralizing and IgG antibodies in unvaccinated female adolescents

Whole blood GBP5 protein levels in patients with and without active tuberculosis

Molecular Evolution of Attachment Glycoprotein (G) and Fusion Protein (F) Genes of Respiratory Syncytial Virus ON1 and BA9 Strains in Xiamen, China

Risk of hepatocellular carcinoma in antiviral treatment-naive chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway (vol 8, pg 549, 2018)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection

A SCID mouse-human lung xenograft model of SARS-CoV-2 infection

Molecular characterization of an uncommon multigene Reassortant G1P[4] rotavirus identified in China

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade

High-Efficiency Plasma Separator Based on Immunocapture and Filtration

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Room-temperature-storable PCR mixes for SARS-CoV-2 detection

Viral neutralization by antibody-imposed physical disruption

Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection

The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus

Construction of a bacterial surface display system based on outer membrane protein F

Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

Characterization of capsid protein (p495) of hepatitis E virus expressed ID in Escherichia coli and assembling into particles in vitro

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway

Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping

Structural basis for the neutralization and genotype specificity of hepatitis E virus

RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo

A rapid and efficient method to express target genes in mammalian cells by baculovirus

Prokaryotical expression of structural and non-structural proteins of hepatitis G virus